Method for removing and reducing Hepatitis C virus
AssigneeJapan Immunoresearch Laboratories Co., Ltd.
InventorsKouji Sawada, Takashi Shimoyama
Life of this patent
Estimating the term…
Abstract
Described is a method of removing and reducing HCV from the blood of an HCV-infected patient, which comprises carrying out, once a day for at least 5 straight days, a treatment of bringing the blood into contact with an adsorptive carrier having a higher affinity for infected, activated and/or defective leukocytes than for uninfected leukocytes. The treatment according to the present invention makes it possible to markedly reduce the blood HCV level of a patient suffering from Hepatitis C, thereby enabling antiviral therapy, for example, treatment with interferon. This brings a drastic improvement in the cure rate for Hepatitis C.
Claims11
A method for removing and reducing HCV from the blood of an HCV-infected patient, which comprises carrying out, once a day for at least 5 straight days, a treatment of bringing the blood into contact with an adsorptive carrier having a higher affinity for infected, activated and/or defective leukocytes than for uninfected leukocytes.
A method of any one of claims 1 to 7, wherein one treatment of bringing the blood into contact with the adsorptive carrier is conducted for 10 minutes to 10 hours at a rate of 5 to 200 mL/min.
A method of treating HCV infection, which comprises carrying out, once a day for at least 5 straight days, a treatment of bringing the blood of an HCV-infected patient into contact with an adsorptive carrier having a higher affinity for infected, activated and/or defective leukocytes than for uninfected leukocytes and then administering interferon to the patient.
Dependencies are inferred from the claim text.